ArticleLancet (London, England)2003
Comparative analysis of the SARS coronavirus genome: a good start to a long journey.
Article in Lancet (London, England), 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Corona Viruses: A Review on SARS, MERS and COVID-19.Microbiology insights · 2021Review
- Severe Acute Respiratory Syndrome Coronavirus (SARS, SARS CoV).Disease-a-month : DM · 2020Review
- Human pathogen coronaviruses - An overview.Disease-a-month : DM · 2020Review
- EMERGING RESPIRATORY DISEASE - CORONAVIRUSES.Disease-a-month : DM · 2017Review
- Responding to global infectious disease outbreaks: lessons from SARS on the role of risk perception, communication and management.Social science & medicine (1982) · 2006Article
- Real-time NASBA detection of SARS-associated coronavirus and comparison with real-time reverse transcription-PCR.Journal of medical virology · 2005Article
- Rapid and sensitive detection of multiple genes from the SARS-coronavirus using quantitative RT-PCR with dual systems.Journal of medical virology · 2005Article
- Prediction of quaternary assembly of SARS coronavirus peplomer.Biochemical and biophysical research communications · 2004Article
- Moderate mutation rate in the SARS coronavirus genome and its implications.BMC evolutionary biology · 2004Article
- Evidence from the evolutionary analysis of nucleotide sequences for a recombinant history of SARS-CoV.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2004Article
Corrections and comments
- Comment on
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.